tyrphostin a23 has been researched along with Synovioma in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Synovial sarcoma is a soft tissue cancer associated with a recurrent t(X:18) translocation that generates one of two fusion proteins, SYT-SSX1 or SYT-SSX2." | 1.34 | The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway. ( Barco, R; Benesh, A; Caldwell, RL; Eid, JE; Frump, AL; Garcia, CB; Hunt, LB, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barco, R | 1 |
| Hunt, LB | 1 |
| Frump, AL | 1 |
| Garcia, CB | 1 |
| Benesh, A | 1 |
| Caldwell, RL | 1 |
| Eid, JE | 1 |
1 other study available for tyrphostin a23 and Synovioma
| Article | Year |
|---|---|
The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.
Topics: Animals; Cell Proliferation; Cell Shape; Cytoskeleton; Enzyme Activation; Ephrins; Gene Expression R | 2007 |